Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

XAIR Insider Trading

Beyond Air, Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Beyond Air, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-07-23 23:05 2025-07-21 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $3.25 6,000 $19,491 3,327,411 +0.2%
2025-03-17 15:15 2025-03-14 Carey Robert Director BUY $0.25 1,000,000 $250,000 4,076,864 +32.5%
2025-02-22 01:00 2025-02-19 Gaul Michael A. Officer - Chief Operating Officer BUY $0.38 6,000 $2,294 94,150 +6.8%
2024-10-02 04:58 2024-09-26 Carey Robert Director BUY $0.50 1,476,626 $744,662 1,476,626 +100.0%
2024-10-02 04:27 2024-09-26 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $0.50 1,476,626 $744,662 3,249,411 +83.3%
2024-08-19 13:06 2024-08-15 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $0.37 50,000 $18,340 1,772,785 +2.9%
2024-08-16 00:09 2024-08-14 Lucera Erick Director BUY $0.40 39,266 $15,565 43,608 +904.3%
2024-08-16 00:09 2024-08-14 Carey Robert Director BUY $0.40 100,000 $39,680 3,076,864 +3.4%
2024-08-16 00:09 2024-08-14 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $0.39 100,000 $38,640 1,722,785 +6.2%
2023-12-30 00:23 2023-12-28 Avniel Amir Director, Officer - Chief Business Officer SELL $2.06 25,000 $51,450 0 -100.0%
2023-12-30 00:15 2023-12-27 Myers Jeff Lynn Officer - Chief Medical Officer SELL $2.21 3,423 $7,579 46,577 -6.8%
2023-12-20 01:15 2023-12-18 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $1.63 77,775 $126,797 1,536,471 +5.3%
2023-12-20 01:13 2023-12-18 Carey Robert Director BUY $1.64 1,200,000 $1,962,000 2,374,454 +102.2%
2023-11-18 00:15 2023-11-16 Gaul Michael A. Officer - Chief Operating Officer BUY $1.77 10,000 $17,700 88,150 +12.8%
2023-08-29 23:10 2023-08-28 Carey Robert Director BUY $2.70 250,000 $673,750 1,225,160 +25.6%
2023-08-22 23:10 2023-08-18 Carey Robert Director BUY $2.75 88,664 $243,392 975,160 +10.0%
2023-07-05 23:05 2023-06-30 Gaul Michael A. Officer - Chief Operating Officer BUY $4.51 5,000 $22,550 78,150 +6.8%
2023-04-03 23:15 2023-03-31 Forbes William P Director BUY $6.67 5,000 $33,350 14,855 +50.7%
2023-03-31 01:39 2023-03-29 Carey Robert Director BUY $6.38 20,000 $127,500 886,496 +2.3%
2023-03-30 00:47 2023-03-28 Lee Yoori Director BUY $6.34 3,115 $19,749 12,654 +32.7%
2023-03-27 23:05 2023-03-24 Gaul Michael A. Officer - Chief Operating Officer BUY $6.15 1,000 $6,150 73,150 +1.4%
2023-03-21 23:05 2023-03-17 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $6.46 10,000 $64,600 1,458,696 +0.7%
2023-03-21 23:05 2023-03-20 BENTSUR RON Director BUY $6.48 2,300 $14,904 144,736 +1.6%
2023-03-20 23:10 2023-03-16 Lucera Erick Director BUY $6.82 2,000 $13,634 4,342 +85.4%
2023-03-20 23:05 2023-03-17 Forbes William P Director BUY $6.46 5,000 $32,300 9,855 +103.0%
2023-03-15 23:05 2023-03-13 Avniel Amir Director, Officer - Chief Business Officer BUY $6.40 1,000 $6,400 457,027 +0.2%
2023-03-15 23:05 2023-03-13 Carey Robert Director BUY $6.64 14,173 $94,164 866,496 +1.7%
2023-03-10 00:05 2023-03-07 Gaul Michael A. Officer - Chief Operating Officer BUY $5.86 8,000 $46,880 72,150 +12.5%
2023-03-10 00:05 2023-03-07 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $5.97 50,000 $298,355 1,447,849 +3.6%
2023-03-10 00:05 2023-03-08 Carey Robert Director BUY $5.95 10,000 $59,500 852,323 +1.2%
2023-02-18 00:30 2023-02-16 Lisi Steven A. Director, Officer - CEO and Chairman of the Board SELL $6.10 48,596 $296,436 1,397,849 -3.4%
2022-12-10 00:15 2022-12-07 Carey Robert Director BUY $5.75 20,000 $115,000 842,323 +2.4%
2022-12-01 00:05 2022-11-28 Carey Robert Director BUY $5.75 30,000 $172,491 822,323 +3.8%
2022-11-19 04:35 2022-11-16 Carey Robert Director BUY $5.88 50,000 $294,000 792,323 +6.7%
2022-08-22 23:52 2022-08-22 Gaul Michael A. Officer - Chief Operating Officer BUY $9.42 2,000 $18,840 64,150 +3.2%
2022-07-05 23:47 2022-06-30 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $6.63 73,000 $483,698 1,446,445 +5.3%
2022-07-05 23:45 2022-06-30 Carey Robert Director BUY $6.45 175,000 $1,128,295 742,323 +30.8%
2022-07-05 23:45 2022-06-30 Avniel Amir Director, Officer - COO and President SELL $6.51 68,100 $443,072 13,733 -83.2%
2022-07-05 23:44 2022-06-30 BENTSUR RON Director SELL $6.53 40,000 $261,104 142,436 -21.9%
2022-04-06 23:15 2022-04-05 Carey Robert Director BUY $6.71 20,000 $134,200 567,323 +3.7%
2022-03-28 16:34 2022-03-24 Carey Robert Director BUY $6.64 26,185 $173,871 547,323 +5.0%
2022-03-21 23:32 2022-03-17 Carey Robert Director BUY $6.75 20,000 $135,000 521,138 +4.0%
2022-01-04 00:15 2021-12-29 Lisi Steven A. Director, Officer - CEO and Chairman of the Board SELL $9.53 21,376 $203,756 1,150,111 -1.8%
2021-12-28 00:15 2021-12-22 Carey Robert Director BUY $9.50 10,000 $95,000 518,418 +2.0%
2021-12-14 00:15 2021-12-10 Lisi Steven A. Director, Officer - CEO and Chairman of the Board BUY $8.53 40,000 $341,200 1,171,487 +3.5%
2021-12-04 00:15 2021-12-01 Avniel Amir Director, Officer - COO and President SELL $13.72 32,675 $448,301 403,527 -7.5%
2021-11-27 01:19 2021-11-24 BENTSUR RON Director SELL $13.53 37,464 $507,071 182,436 -17.0%
2021-11-27 01:16 2021-11-23 Carey Robert Director BUY $12.35 5,000 $61,750 508,418 +1.0%
2021-11-25 00:10 2021-11-22 Carey Robert Director BUY $12.05 10,000 $120,500 503,418 +2.0%
2021-11-24 00:50 2021-11-19 Carey Robert Director BUY $14.10 12,000 $169,200 493,418 +2.5%
SHOW ENTRIES
1-50 OF 110

How to Interpret $XAIR Trades

Not every insider transaction in Beyond Air, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $XAIR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for XAIR

Insider activity data for Beyond Air, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $XAIR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.